Publication | Closed Access

Cost-Utility Analysis of Tissue Plasminogen Activator Therapy for Acute Ischaemic Stroke

ThrombosisCost-utility AnalysisCardiovascular DiseaseIschemic StrokeMedicineStroke-related ConditionCerebrovascular DiseaseRehabilitationNeurologyCerebrovascular InterventionCerebral Blood FlowPublic HealthStrokeAtherosclerosisIschemic SyndromeAcute Ischaemic StrokeReperfusion Injury